Axsome Therapeutics 2017 BIO CEO Investor Conference

Loading viewer...

conference

Format: PDF conference

Axsome Therapeutics presented an overview of its business and clinical pipeline at the BIO CEO & Investor Conference in February 2017. The presentation highlighted the company's late-stage clinical product candidates AXS-05 and AXS-02, delivered by CEO Herriot Tabuteau, M.D.

Browse all conferences →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Axsome Therapeutics

View all →

presentation

Similar conferences from other companies

Browse all →

Ammonia Energy Association Clean Hydrogen 2021 Workshop

conference

9 Pages

Ammonia Energy Association

Fifth Third Bancorp Emerging Payments Forum 2017

conference